ZD4190: An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy

Cancer Research

Volumn 60, Issue 4, 2000, Pages 970-975

  Wedge, Stephen R ^a   Ogilvie, Donald J ^a   Dukes, Michael ^a   Kendrew, Jane ^a   Curwen, Jon O ^a   Hennequin, Laurent F ^a   Thomas, Andrew P ^a   Stokes, Elaine S E ^a   Curry, Brenda ^a   Richmond, Graham H P ^a   Wadsworth, Peter F ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; PROTEIN TYROSINE KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSTASIS; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; EPIPHYSES; FEMALE; HUMANS; HYPERTROPHY; MICE; NEOPLASM TRANSPLANTATION; QUINAZOLINES; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 0034652716     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Ishigami, S-I., Arii, S., Furutani, M., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., and Imamura, M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer, 78: 1379-1384, 1998.
2. Salven, P., Heikkila, P., and Joensuu, H. Enhanced expression of vascular endothehal growth factor in metastatic melanoma. Br. J. Cancer, 76: 930-934, 1997.
3. Shibusa, T., Shijubo, N. And Abe, S. Tumour angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin. Cancer Res., 4: 1483-1487, 1998.
4. Okita, S., Kondoh, S., Shiraishi, K., Kaino, S., Hatano, S., and Okita, K. Expression of vascular endothelial growth factor correlates with tumour progression in gallbladder cancer clinical studies. Int. J. Oncol., 12: 1013-1018, 1998.
5. Abdulrauf, S. I., Edvardsen, K., Ho, K. L., Yang, X. Y., Rock, J. P., and Rosenblum, M. L. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J. Neurosurg., 88: 513-520, 1998.
6. Eppenberger, U., Kueng, W., Schlaeppi, J-M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., Schmitt, M., Foekens, J. A., and Eppenberger-Castori, S. Markers of tumour angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol., 16: 3129-3136, 1998.
7. Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
8. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochern. Biophys. Res. Commun., 189: 824-831, 1992.
9. Pepper, M. S., Ferrara, N, Orci, L., and Montesano, R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun., 181: 902-906, 1991.
10. Unemori, E. N., Ferrari, N., Bauer, E. A., and Amento, E. P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol., 153: 557-562, 1992.
11. Lamoreaux, W. J., Fitzgerald, M. E., Reiner, A., Hasty, K. A., and Charles, S. T. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvaseular endothelial cells in vitro. Microvasc. Res., 55: 29-42, 1998.
12. Senger, D. R., Ledbetter, S. R., Claffey, K. P., Papadopoulos-Sergio, A., Perruzzi, C. A., and Detmar, M. Stimulation of endothelial cell migration by vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am. J. Pathol., 149: 293-305, 1996.
13. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., and Detmar, M. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2α2 integrins. Proc. Natl. Acad. Sci. USA, 94: 13612-13617, 1997.
14. Dvorak, H. F., Detmar, M., Claffey, K. P., Nagy, J. A., van de Water, L., and Senger, D. R. Vascular permeability factor/vascular endothelial growth factor an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Appl. Immunol., 107: 233-235, 1995.
15. Roberts, W. G., and Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res., 57: 765-772, 1997.
16. Finkenzeller, G., Marmé, D., Weich, H. A., and Hug, H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res., 52: 4821-4823, 1992.
17. Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
18. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., and Levi, B. Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271: 736-741, 1996.
19. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids-implications for tumour angiogenesis. Proc. Natl. Acad. Sci. USA, 92: 768-772, 1995.
20. Rak, J., Mitsuhashi, L., Bayo, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumour angiogenesis. Cancer Res., 55: 4575-4580, 1995.
21. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
22. Mukhopadhyay, D., Tsiokas, L., Zhou, X-M., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-580, 1995.
23. Saez, E., Rutberg, S. E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S. H., and Spiegelman, B. M. c-fos is required for malignant progression for skin tumours. Cell, 82: 721-732, 1995.
24. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55: 6161-6165, 1995.
25. Damert, A., Machein, M., Breier, G., Fujita, M. Q., Hanahan, D., Risau, W., and Plate, K. H. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res., 57: 3860-3864, 1997.
26. Dibbens, J. A., Miller, D. L., Damert, A., Risau, W., Vadas, M. A., and Goodall, G. J. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell, 10: 907-919, 1999.
27. Shen, H., Clauss, M., Ryan, J., Schmidt, A. M., Tijburg, P., Borden, L., Connolly, D., Stem, D., and Kao, J. Characterisation of vascular-permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood, 81: 2767-2773, 1993.
28. Yarnagishi, S., Yonekura, H., Yamamoto, Y., Fujimori, H., Sakurai, S., Tanaka, N., and Yamamoto, H. Vascular endothelial growth factor acts, as a pericyte mitogen under hypoxic conditions. Lab. Investig., 79: 501-509, 1999.
29. Wang, H., and Keiser, J. A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of Flt-I. Circ. Res., 83: 832-840, 1998.
30. Plate, K H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59: 520-529, 1994.
31. Fuh, G., Li, B., Crowley, C., Cunningham, B., and Wells, J. A. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J. Biol. Chem., 273: 11197-11204, 1998.
32. 2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett.. 420: 28-32, 1997.
33. Takahashi, T., Ueno, H., and Shibuya, M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene, 18: 2221-2230, 1999.
34. Rousseau. S., Houle, F., Landry, J., and Huoi, J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene, 15: 2169-2177, 1997.
35. Abedi, H., and Zachary, I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem., 272: 15442-15451, 1997.
36. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
37. Kanai. T., Konno, H., Tanaka, T., Baba, M., Matsumoto, K., Nakamura, S., Yukita, A., Asano, M., Suzuki, H., and Baba, S. Anti-tumour and anti-melastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted ortholopically into nude mice. Int. J. Cancer, 77: 933-936, 1998.
38. Zhu, Z., Rockwell, P., Lu, D., Kotanides, H., Pytowski, B., Hicklin, D. J., Bohlen, P., and Witte, L. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single chain antibodies from a phage display library. Cancer Res., 58: 3209-3214, 1998.
39. Siemeister, G., Schimer, M., Reusch, P., Barleon, B., Marme, D., and Martiny-Baron, G. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA, 95: 4625-4629, 1998.
40. Lin, P., Sankar, S., Shan, S., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q., and Peters, K. G. Inhibition of tumour growth by targeting tumour endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ., 9: 49-58, 1998.
41. Cheng, S-Y., Huang, H-J, S., Nagane, M., Ji, X-D., Wang, D., Shin, C. C-Y., Arap, W., Huang, C-M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
42. Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., and Strawn, L. M. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumour types in vivo. Cancer Res., 56: 1615-1620, 1996.
43. Ke, L. D., Fueyo, J., Chen, X., Steck, P. A., Shi, Y-X., Im, A-A., and Yung, W. K. A. A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes. Int. J. Oncol., 12: 1391-1396, 1998.
44. Hennequin, L. F., Thomas, A. P., Johnstone, C., Stokes, E. S. E., Plé. P. A., Lohmann, J. M., Ogilvie, D. J., Dukes, M., Wedge, S. R., Curwen, J. O., Kendrew, J., and Lambert-van der Brempt, C. Design and structure-activity relationship of a new class of potent VEGF receptor lyrosine kinase inhibitors. J. Med. Chem., 42: 5369-5389, 1999.
45. Gerber, H-P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med., 5: 623-628, 1999.
46. Schenk, R. K., Weiner, J., and Shapiro, D. The structural aspects of vascular invasion of the tibial epiphyscal plate of growing rats. Acta Anat., 68: 1-17, 1968.
47. Homer, A., Bishop, N. J., Bord, S., Beeton, C., Kelsall, A. W., Coleman, N., and Compston, J. E. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plale cartilage. J. Anat., 194: 519-524, 1999.
48. Ryan, A. M., Eppler, D. B., Hagler, K. E., Bruner, R. H., Thomford, P. J., Hall, R. L., Shopp, G. M., and O'Niell, C. A. Preclinical safety evaluation of rbuMAbVEGF, an antiangiogenic humanised monoclonal antibody. Toxicol, Pathol., 27: 78-86, 1999.
49. Borgström, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumours by anti-vascular endothelial growth factor neutralizing antibodies. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
50. Fong, T. A., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, P., and McMahon, G. SU5416 is a potent and selective inhibitor of the vascular cndothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumour vascularisation, and growth of multiple tumour types. Cancer Res., 59: 99-106, 1999.
51. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C-H. Different signal transduction properties of KDR and Flt-1: two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
52. Olander, J. V., Connolly, D. T., and DeLarco, J. E. Specific binding of vascular permeability factor to endothelial cells. Biochem. Biophys. Res. Commun., 175: 68-76, 1991.
53. Sawano, A., Takahashi, T., Yamaguchi, S., and Shibuya, M. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCγ. Biochem. Biophys. Res. Commun., 238: 487-491, 1997.
54. Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S., and Fusenig, N. E. Halting angiogenesis suppresses carcinoma cell invasion. Nat. Med., 3: 1222-1227, 1997.
55. Ortéga, N., Jonca, F., Vincent, S., Favard, C., Ruchoux, M-M., and Plouët, J. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am. J. Pathol., 151: 1215-1224, 1997
56. Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y., and Shibuya, M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem., 273: 31273-31282, 1998.
57. Park, J. E., Chen, H. H., Winer, J., Houck, A. A., and Ferrara, N. J. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity in vitro and in vivo and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem., 269: 25646-25654, 1994.
58. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziche, M., Lanz, C., Büttner, M., Rziha, H-J., and Dehio, C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1 ) receptor tyrosine kinase. EMBO J., 18: 363-374, 1999.
59. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res., 53: 5822-5827, 1993.
60. Takahashi, Y., Kitadal, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
61. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA, 95: 9349-9354, 1998.
62. Fong, G-H., Rossant, J., Gertsenstein, M., and Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (Lond.), 376: 66-70, 1995.
63. Landgren, E., Schiller, P., Cao, Y., and Claesson-Welsh, L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1. Oncogene, 16: 359-367, 1998.
64. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., and Marmé, D. Migration of human monocytes in response to human vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87: 3336-3343, 1996.
65. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J., and Risau, W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J. Biol. Chem., 30: 17629-17634, 1996.
66. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, W., Carbone, D. P., and Gabrilovich, D. I. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-KκB activation in hemopoietic progenitor cells. J. Immunol., 160: 1224-1232, 1998.
67. Achen, M. G., and Stacker, S. A. The vascular endothelial growth factor family: proteins which guide the development of the vasculature. Int. J. Exp. Pathol., 79: 255-265, 1998.
68. Alon, T., Hemo, I., Itin, A., Pe'ee, J., Stone, J., and Keshet, E. Vascular endothelial factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
69. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. Selective ablation of immature blood vessels in established human tumours follows vascular endothelial growth factor withdrawal. J. Clin. Investig., 103: 159-165, 1999.
70. Nör, J. E., Christensen, J., Mooney, D. J., and Polverini, P. J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol., 154: 375-384, 1999.
71. Wedge, S. R., Waterton, J. C., Tessier, J. J., Checkley, D., Dukes, M., Kendrew, J., and Curry, B. Effect of the VEGF receptor tyrosine kinase inhibitor ZD4190 on vascular endothelial permeability. Proc. Am. Assoc. Cancer Res., 40: 2741, 1999.
72. Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., and Ferrara, N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152: 149-152, 1994.
73. Adamis, A. P., Increased endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol., 118: 445-450, 1994.